Treatment of gastroduodenal ulcer by "Ulcosilvanil".
"Ulcosilvanil" (Romanian registered mark), administered in duodenal and gastric ulcer patients, leads to a constant and long-lasting inhibition of gastric acid secretion, consequently to disappearance of subjective symptoms as well as to radiologically and endoscopically proved healing of the crater. The high percentage and the quick ulcer healing by "Ulcosilvanil", as compared with antacid and anticholinergic therapy or with H2-receptor blocking agents, prove the outstanding therapeutical value of the former.
D000086:Acetazolamide / Q000627:therapeutic use*; D001639:Bicarbonates / Q000627:therapeutic use*; D004338:Drug Combinations / Q000627:therapeutic use; D005744:Gastric Acid / Q000378:metabolism; D006801:Humans; D010437:Peptic Ulcer / Q000188:drug therapy*
D001639:Bicarbonates; D004338:Drug Combinations; C030084:Ulcosilvanil; D000086:Acetazolamide